Before struggling with protein expression systems, why not try synthesizing it? An enzymatic protein synthesis kit is now available at an affordable price!
"Can it really be synthesized?" "It seems like the synthesis amount is small..." "This is my first time with a cell-free system..." Such anxieties and concerns can be resolved! We provide full support. With PUREfrex2.0 mini, which includes common primers for all proteins, please first try to see if your protein can be synthesized. ■ What is PUREfrex? PUREfrex is a kit that reproduces the protein synthesis reaction that occurs inside cells, such as E. coli, in a tube. By adding the gene of the protein you want to synthesize to the kit and reacting it at 37°C for 4 hours, the desired protein will be synthesized. It is recommended for when you want to try a little during preliminary experiments or when you need multiple proteins. You can confirm the synthesis amount with a small volume of reaction solution, and then increase the volume of the reaction solution to synthesize the required amount. 【Features】 ■ Synthesis is possible on a scale from a few μL to several tens of mL ■ Additive selection can be customized according to the protein being synthesized ■ Bulk orders are also supported (hundreds of mL to L) ■ Customization of the reaction solution is also available For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
Product Lineup ________________ 【Protein Synthesis Reaction Solution】 ◆ PUREfrex 1.0: For basic research (composition disclosed) ◆ PUREfrex 2.0: For protein synthesis (composition undisclosed) 【Additives】 ◆ Promoting the formation of disulfide bonds: DsbC/PDI ◆ Chaperones: DnaK Mix/GroE Mix
Price range
P2
Delivery Time
P2
※If there is product inventory
Applications/Examples of results
For more details, please contact us.
catalog(1)
Download All CatalogsCompany information
Gene Frontier has been expanding its business areas that contribute to the acceleration of biopharmaceuticals, including antibody drugs, and has been advancing the development of its unique technologies. Moving forward, we aim to accelerate our research and development and business development to achieve further growth on a global scale. We will continue to provide unique technologies and services for the development of innovative pharmaceuticals and diagnostic drugs, striving to be a trusted partner for our customers and contribute to 21st-century healthcare.